Skip to content

Research on efficacy of Shengmai Yin in the treatment of normal tension glaucoma

Research on efficacy of Shengmai Yin in the treatment of normal tension glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029273
Enrollment
Unknown
Registered
2020-01-19
Start date
2020-08-31
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Tension Glaucoam

Interventions

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of normal tension glaucoma, adhere to drugs to reduce intraocular pressure treatment. 2. Aged 18-60 years old; 3. Informed willing to participate in the research project, and signed the informed consent; 4. Have the ability to walk independently or subsequent visit, correct visual acuity >=0.7, ensure accurate visual field examination.

Exclusion criteria

Exclusion criteria: 1. The diagnosis was NTG, but the age was not within 18-60 years old. 2. Severe systemic disease or cardiopulmonary dysfunction was found after inclusion, and no tuberculosis or malignant tumor was found, which required medical treatment to keep the whole body healthy. 3. After enrollment, patients may apply for withdrawal from the study for any reason. 4. After enrollment, because the intervention methods adopted in the study could not effectively prevent the progression of NTG. In the first 6 months, visual field defects with MD exceeding -5.0dB or above appeared in either eye, or surgical intervention was required.

Design outcomes

Primary

MeasureTime frame
Visual Field Index, Optic Nerve Blood Flow, Blood Pressure;

Countries

China

Contacts

Public ContactQing Guoping

Beijing Tongren Hospital

gptsing@126.com+86 15801224486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026